125 related articles for article (PubMed ID: 2223572)
1. Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.
Tozer GM; Maxwell RJ; Griffiths JR; Pham P
Br J Cancer; 1990 Oct; 62(4):553-60. PubMed ID: 2223572
[TBL] [Abstract][Full Text] [Related]
2. The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours.
Burney IA; Maxwell RJ; Griffiths JR; Field SB
Br J Cancer; 1991 Oct; 64(4):683-8. PubMed ID: 1911217
[TBL] [Abstract][Full Text] [Related]
3. Spatial heterogeneity of the metabolic response of RIF-1 tumors to a vasoactive agent evaluated in vivo by one-dimensional 31P chemical-shift imaging.
Bhujwalla ZM; Blackband SJ; Wehrle JP; Glickson JD
Magn Reson Med; 1992 Aug; 26(2):308-12. PubMed ID: 1513252
[TBL] [Abstract][Full Text] [Related]
4. Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy.
Okunieff P; Kallinowski F; Vaupel P; Neuringer LJ
J Natl Cancer Inst; 1988 Jul; 80(10):745-50. PubMed ID: 3385782
[TBL] [Abstract][Full Text] [Related]
5. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
6. The energy metabolism of RIF-1 tumours following hydralazine.
Bhujwalla ZM; Tozer GM; Field SB; Maxwell RJ; Griffiths JR
Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156
[TBL] [Abstract][Full Text] [Related]
7. Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
Burney IA; Maxwell RJ; Field SB; McCoy CL; Griffiths JR
Acta Oncol; 1995; 34(3):367-71. PubMed ID: 7779425
[TBL] [Abstract][Full Text] [Related]
8. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.
Bhujwalla ZM; Tozer GM; Field SB; Proctor E; Busza A; Williams SR
NMR Biomed; 1990 Aug; 3(4):178-83. PubMed ID: 2206850
[TBL] [Abstract][Full Text] [Related]
9. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.
Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC
Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643
[TBL] [Abstract][Full Text] [Related]
10. The effects of hypovolemic hypotension on high-energy phosphate metabolism of traumatized brain in rats.
Ishige N; Pitts LH; Berry I; Nishimura MC; James TL
J Neurosurg; 1988 Jan; 68(1):129-36. PubMed ID: 3335898
[TBL] [Abstract][Full Text] [Related]
11. Effects of pentobarbital anesthesia on the energy metabolism of murine tumors studied by in vivo 31P nuclear magnetic resonance spectroscopy.
Okunieff P; Rummeny E; Vaupel P; Skates S; Willett C; Neuringer LJ; Suit HD
Radiat Res; 1988 Aug; 115(2):361-72. PubMed ID: 3406373
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
Nordsmark M; Maxwell RJ; Wood PJ; Stratford IJ; Adams GE; Overgaard J; Horsman MR
Br J Cancer Suppl; 1996 Jul; 27():S232-5. PubMed ID: 8763887
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.
Beauregard DA; Thelwall PE; Chaplin DJ; Hill SA; Adams GE; Brindle KM
Br J Cancer; 1998 Jun; 77(11):1761-7. PubMed ID: 9667644
[TBL] [Abstract][Full Text] [Related]
14. Effect of systemic hypotension on cerebral energy metabolism during chronic cerebral vasospasm in primates.
Handa Y; Kubota T; Tsuchida A; Kaneko M; Caner H; Kobayashi H; Kubota T
J Neurosurg; 1993 Jan; 78(1):112-9. PubMed ID: 8416225
[TBL] [Abstract][Full Text] [Related]
15. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy.
Li SJ; Wehrle JP; Rajan SS; Steen RG; Glickson JD; Hilton J
Cancer Res; 1988 Sep; 48(17):4736-42. PubMed ID: 3409214
[TBL] [Abstract][Full Text] [Related]
16. Sequential in vivo measurement of cerebral intracellular metabolites with phosphorus-31 magnetic resonance spectroscopy during global cerebral ischemia and reperfusion in rats.
Andrews BT; Weinstein PR; Keniry M; Pereira B
Neurosurgery; 1987 Nov; 21(5):699-708. PubMed ID: 3696405
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
18. Excitatory effects of the vasodilator hydralazine on acoustic startle in the rat.
Commissaris RL; Davis M
Pharmacol Biochem Behav; 1983 Nov; 19(5):891-4. PubMed ID: 6647523
[TBL] [Abstract][Full Text] [Related]
19. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
Lyng H; Olsen DR; Southon TE; Rofstad EK
Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance spectroscopy studies on experimental murine and human tumors: comparison of changes in phosphorus metabolism with induced changes in vascular volume.
Adams GE; Bremner JC; Counsell CJ; Stratford IJ; Thomas C; Wood PJ
Int J Radiat Oncol Biol Phys; 1992; 22(3):467-71. PubMed ID: 1735680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
